| Cell line name | PFIZi012-A |
|---|---|
| Synonyms | FB66c17; RCi198 |
| Accession | CVCL_VE73 |
| Resource Identification Initiative | To cite this cell line use: PFIZi012-A (RRID:CVCL_VE73) |
| Comments | From: Pfizer, Inc.; New York; USA. Cell type: Fibroblast; CL=CL_0000057. |
| Disease | Chromosome 16p11.2 deletion syndrome (NCIt: C120408) Proximal 16p11.2 microdeletion syndrome (ORDO: Orphanet_261197) |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Sex of cell | Sex unspecified |
| Age at sampling | Age unspecified |
| Category | Induced pluripotent stem cell |
| Cross-references | |
| Cell line collections (Providers) | EBiSC; PFIZi012-A
ECACC; 66540228 - Discontinued |
| Cell line databases/resources | hPSCreg; PFIZi012-A |
| Biological sample resources | BioSamples; SAMEA4097192 |
| Encyclopedic resources | Wikidata; Q54947266 |
| Entry history | |
| Entry creation | 14-May-2018 |
| Last entry update | 30-Jan-2024 |
| Version number | 8 |